Display options
Share it on

Int J Surg Oncol. 2012;2012:245385. doi: 10.1155/2012/245385. Epub 2011 Sep 11.

Metastatic Medulloblastoma in Childhood: Chang's Classification Revisited.

International journal of surgical oncology

Christelle Dufour, Annick Beaugrand, Barry Pizer, Julie Micheli, Marie-Stephanie Aubelle, Aurelie Fourcade, Dominique Couanet, Agnes Laplanche, Chantal Kalifa, Jacques Grill

Affiliations

  1. Department of Pediatric and Adolescent Oncology, Institute Gustave Roussy, 114 rue Edouard Vaillant, 94805 Villejuif, France.

PMID: 22312539 PMCID: PMC3265270 DOI: 10.1155/2012/245385

Abstract

Purpose. To correlate the radiological aspects of metastases, the response to chemotherapy, and patient outcome in disseminated childhood medulloblastoma. Patients and Methods. This population-based study concerned 117 newly diagnosed children with disseminated medulloblastoma treated at the Institute Gustave Roussy between 1988 and 2008. Metastatic disease was assessed using the Chang staging system, their form (positive cerebrospinal fluid (CSF), nodular or laminar), and their extension (positive cerebrospinal fluid, local, extensive). All patients received preirradiation chemotherapy. Results. The overall survival did not differ according to Chang M-stage. The 5-year overall survival was 59% in patients with nodular metastases compared to 35% in those with laminar metastases. The 5-year overall survival was 76% in patients without disease at the end of pre-irradiation chemotherapy compared to 34% in those without a complete response (P = 0.0008). Conclusions. Radiological characteristics of metastases correlated with survival in patients with medulloblastoma. Complete response to sandwich chemotherapy was a strong predictor of survival.

References

  1. Eur J Cancer. 2005 Mar;41(5):727-34 - PubMed
  2. J Clin Oncol. 1999 Mar;17(3):832-45 - PubMed
  3. Radiology. 1969 Dec;93(6):1351-9 - PubMed
  4. Lancet Oncol. 2006 Oct;7(10):813-20 - PubMed
  5. Pediatr Blood Cancer. 2007 Apr;48(4):408-15 - PubMed
  6. J Neurosurg. 1994 Nov;81(5):690-8 - PubMed
  7. Int J Radiat Oncol Biol Phys. 2006 Apr 1;64(5):1325-30 - PubMed
  8. Int J Radiat Oncol Biol Phys. 1996 Aug 1;36(1):29-35 - PubMed
  9. Eur J Cancer. 1994;30A(10):1478-83 - PubMed
  10. Eur J Cancer. 2006 Nov;42(17):3004-14 - PubMed
  11. Control Clin Trials. 1996 Aug;17(4):343-6 - PubMed
  12. J Neurosurg. 1990 Apr;72(4):572-82 - PubMed
  13. Med Pediatr Oncol. 1994;23(5):422-7 - PubMed
  14. Int J Radiat Oncol Biol Phys. 2000 Jan 15;46(2):269-79 - PubMed
  15. Neurosurgery. 1996 Feb;38(2):265-71 - PubMed
  16. J Neurooncol. 2008 Dec;90(3):351-5 - PubMed
  17. Med Pediatr Oncol. 1995 Sep;25(3):166-78 - PubMed
  18. AJNR Am J Neuroradiol. 2000 Oct;21(9):1757-65 - PubMed
  19. Bone Marrow Transplant. 2001 Mar;27(5):471-7 - PubMed
  20. J Chronic Dis. 1978;31(8):557-60 - PubMed
  21. Ann Oncol. 1999 Feb;10(2):239-41 - PubMed

Publication Types